Mirum Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for th…

Biotechnology
US, Foster City [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Mirum Pharmaceuticals, Inc. has no acquisition track records yet.

M&A Deals · History

Mirum Pharmaceuticals, Inc. has no acquisition track records yet.

End of MIRM's Analysis
CIK: 1759425 CUSIP: 604749101 ISIN: US6047491013 LEI: - UEI: -
Secondary Listings
MIRM has no secondary listings inside our databases.